However, the abundance of this peptide-epitope in HLA-A3 molecules expressed either on syngeneic tumour cells or HER-2(9369)-pulsed syngeneic DC will activate these clones to produce cytokines (e.g. IFN-γ) and lyse their specific targets. This evidence concerns the gene ERBB2 and neoplasm.